about
A deficiency in dolichyl-P-glucose:Glc1Man9GlcNAc2-PP-dolichyl alpha3-glucosyltransferase defines a new subtype of congenital disorders of glycosylationIdentification and characterization of a cDNA encoding a dolichyl pyrophosphate phosphatase located in the endoplasmic reticulum of mammalian cellsMass spectrometric characterization of proteins from the SARS virus: a preliminary report.Update and perspectives on congenital disorders of glycosylation.Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds.Proteome-wide analysis of single-nucleotide variations in the N-glycosylation sequon of human genesFrequency Determination of α-1,3 Glucosyltransferase p.Y131H and p.F304S Polymorphisms in the Croatian Population Revealed Five Novel Single Nucleotide Polymorphisms in the hALG6 GeneGlycan evolution in response to collaboration, conflict, and constraintDarwinian selection for sites of Asn-linked glycosylation in phylogenetically disparate eukaryotes and viruses.Posttranscriptional regulation of uridine diphosphate glucuronosyltransferases.Biological roles of glycans.The clinical relevance of glycobiology.rhIGF-1 Therapy for Growth Failure and IGF-1 Deficiency in Congenital Disorder of Glycosylation Ia (PMM2 Deficiency).Differences in N-linked glycosylation between human surfactant protein-B variants of the C or T allele at the single-nucleotide polymorphism at position 1580: implications for disease.Modeling a congenital disorder of glycosylation type I in C. elegans: a genome-wide RNAi screen for N-glycosylation-dependent loci.The molecular landscape of phosphomannose mutase deficiency in iberian peninsula: identification of 15 population-specific mutationsThe relative contribution of mannose salvage pathways to glycosylation in PMI-deficient mouse embryonic fibroblast cells.Functional significance of PMM2 mutations in mildly affected patients with congenital disorders of glycosylation Ia.Rating of CCl(4)-induced rat liver fibrosis by blood serum glycomics.The Analysis of Variants in the General Population Reveals That Is Extremely Tolerant to Missense Mutations and That Diagnosis of PMM2-CDG Can Benefit from the Identification of Modifiers
P2860
Q24336444-F31FCEB4-F27A-4BA6-97F7-9E1A449A3DACQ28588980-A5E3A053-CD4D-4A4F-A043-BAF0A048BC75Q30939828-75634F16-C778-419D-B52A-02C41E5E3A59Q34110629-4E3A54A6-FA97-4D69-A158-DC43132FFFDFQ34131204-D9CC119B-295E-4A31-9E12-8F7584A5397CQ34269085-F0A36989-7EBB-4DC4-B87D-F62045035659Q35693733-D5F1FA4A-EC8F-4638-AFE8-9A26A6684FFDQ36666124-FD659813-5FF8-4493-82B4-104DAF323BE2Q37304124-DB7104EA-4B19-4ECB-90C9-6DAFBC21DCD5Q38386709-90851971-A9EC-49A0-A939-81A9AEAA1F29Q38936714-E6B9C0D6-C8DF-45DD-B6BA-2C1517ED416DQ39912806-A45F533D-3A77-4098-96DD-B51ABBAE5902Q40479090-F6B9570D-5E97-421C-9CF4-62A4D6DF8D73Q40629802-42E42B15-A5ED-41E1-8C45-2A9F7E13A43CQ41971316-AE7FF52C-B226-400A-8123-5010DCDF4C1EQ42367639-EE4C859A-6E19-4727-955B-4D158E23282FQ46794715-8F9DCC79-B9A5-4B8B-9B30-54F756061F90Q46988494-CC3C9177-601C-4FCA-A2E1-C8223BE84378Q49050083-E8402DB4-C9E9-4DD2-89DC-0160655B7B4AQ57976794-C1DD693A-9A19-43D4-9ECC-A6B0BA1E609B
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Balancing N-linked glycosylation to avoid disease
@ast
Balancing N-linked glycosylation to avoid disease
@en
Balancing N-linked glycosylation to avoid disease
@nl
type
label
Balancing N-linked glycosylation to avoid disease
@ast
Balancing N-linked glycosylation to avoid disease
@en
Balancing N-linked glycosylation to avoid disease
@nl
prefLabel
Balancing N-linked glycosylation to avoid disease
@ast
Balancing N-linked glycosylation to avoid disease
@en
Balancing N-linked glycosylation to avoid disease
@nl
P1433
P1476
Balancing N-linked glycosylation to avoid disease
@en
P2093
H H Freeze
V Westphal
P356
10.1016/S0300-9084(01)01292-5
P407
P577
2001-08-01T00:00:00Z